Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC100133772///SLC16A5 |
| Upstream (Parents) |
|---|
| (<<) MGC12488 → LOC100133772///SLC16A5 |
| (<<) PRRG2 → LOC100133772///SLC16A5 |
| (<<) NRIP1 → LOC100133772///SLC16A5 |
| (<<) ZMYM1 → LOC100133772///SLC16A5 |
| (<<) SEPT8 → LOC100133772///SLC16A5 |
| Downstream (Children) |
|---|
| LOC100133772///SLC16A5 → PTCD2 (>>) |
| LOC100133772///SLC16A5 → MGC12488 (>>) |
| LOC100133772///SLC16A5 → BIN1 (>>) |
| LOC100133772///SLC16A5 → CR2 (>>) |
| LOC100133772///SLC16A5 → TTLL7 (>>) |
| LOC100133772///SLC16A5 → GABBR2 (>>) |
| LOC100133772///SLC16A5 → FAM134B (>>) |
| LOC100133772///SLC16A5 → UPK3A (>>) |
| LOC100133772///SLC16A5 → ITGA2B (>>) |
| LOC100133772///SLC16A5 → PDE4B (>>) |
| LOC100133772///SLC16A5 → NRG2 (>>) |
| LOC100133772///SLC16A5 → DPY19L1P1 (>>) |
| LOC100133772///SLC16A5 → ARL17B///ARL17A (>>) |
| LOC100133772///SLC16A5 → CGGBP1 (>>) |
| LOC100133772///SLC16A5 → SLC22A13 (>>) |
| LOC100133772///SLC16A5 → PTPRH (>>) |
| LOC100133772///SLC16A5 → SH3D19///RUNX1 (>>) |
| LOC100133772///SLC16A5 → ABCC3 (>>) |
